Clinical Characteristics and Long-term Surgical Outcome of Spinal Myxopapillary Ependymoma: A French Cohort of 101 Patients

Anne-Sophie Montero(Sorbonne Université), Bertrand Mathon(Sorbonne Université), Chiara Villa(Centre National de la Recherche Scientifique), Aymeric Amelot(Sorbonne Université), S. Gaillard(Hôpital Foch), Ahmed Idbaïh(Centre National de la Recherche Scientifique), L. Feuvret(Sorbonne Université), Marc Polivka(Hôpital Lariboisière), Alexandre Carpentier(Sorbonne Université), Guillaume Lot, Fabrice Parker, Clovis Adam(Université Claude Bernard Lyon 1), Suzanne Tran(Sorbonne Université), Franck Bielle(Centre National de la Recherche Scientifique)
Research Square
February 17, 2021
10.21203/rs.3.rs-231555/v1
Cited by 0

Related Papers

Lomustine and Bevacizumab in Progressive Glioblastoma
|New England Journal of Medicine|2017|994
Genome-wide association study identifies five susceptibility loci for glioma
|Nature Genetics|2009|797
Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated <i>MGMT</i> promoter
|Neuro-Oncology|2022|508
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
|The Lancet Oncology|2016|504
Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors
|Nature Genetics|2017|381